InquirerRidon: GenCorp P2.14M paid to VP Duterte faces closer scrutinySky TG24Grammy 2027, Rosalía, Raye, Ella Langley le artiste con più candidatureThe Jerusalem PostFrance seeks new EU sanctions on Iran over IRGC cyberattacks targeting supermarket refrigeratorsSouth China Morning PostPakistan’s jailed ex-leader Imran Khan appeals for urgent medical careComplete Sports2027 AFCONQ: ‘We’re Motivated To Play This Game’ — Chelle Speaks Ahead Of Super Eagles’ Away Clash With TanzaniaZDF heuteEntdecken Sie das ZDF-Nachrichtenstudioسكاي نيوز عربيةقوات أمنية عراقية مشتركة تتحرك نحو جرف الصخرBBC NewsLindsay Clancy to face retrial next year for deaths of her three childrenThe Straits TimesStand a chance to win a pair of Oceanarium ticketsIl Fatto QuotidianoCop 31 in Turchia, dall’addio ai combustibili fossili al taglio delle emissioni, la prima bozza del documento finale è puro ottimismoNU.nlKNVB spreekt steun uit voor Franse uitdager van Infantino bij FIFA-verkiezingMexico News DailyInterior Minister fills in for Sheinbaum, touting poverty data and approval ratings: Monday’s mañanera recapped
The Daily Newsstand · Free, Always
Monday, November 16, 2026

Former Prime Minister David Cameron: "We really are close to ending Alzheimer's"

Translate

The word “crisis” is used a lot in politics, but when we discuss dementia, I think it’s appropriate. There are more than a million people in the UK – one in 14 people over the age of 65 – living with this horrendous condition. By 2040, the overall number is set to rise to 1.4 million.

As a Member of Parliament, I watched care and nursing homes add wings to accommodate more dementia patients. I witnessed the growing number of people living with dementia, the huge strain it was placing on our health and care systems, and the sorrow of families whose loved ones no longer recognised them.

I became fixated on this issue, but the reason was never especially personal; it was born from my experience as a constituency MP. However, all that changed last year when I lost my dear mother, Mary Cameron, to Alzheimer’s. I watched this strong, intelligent, capable woman disappear into a world of darkness. Finally, I truly knew how all those other families felt. That experience gave me a renewed sense of urgency.

Let’s be clear, dementia is caused by diseases of the brain. As Prime Minister, I believed strongly that we should be researching these diseases and looking for diagnoses, treatments and cures with the same fervour we deploy to tackling strokes, heart disease or cancer.

Back then there were no real preventative measures or treatments, let alone a cure. But I rejected this sense of fatalism. I sought to understand what had gone wrong. The world had made such strides in treating cancer and HIV. Why not dementia?

48_shutterstock_editorial_8296738m

Lord David Cameron and his mother Mary Cameron in 2017. Shutterstock

Partly there was an awareness problem – an attitude that dementia is simply an inevitable part of ageing. Like many, I was guilty of thinking this, but I quickly discovered that I was wrong.

There were also problems with funding and drug discovery. Clinical trials take years, with each stage costing millions of pounds. Research had reached many dead ends, not least because it’s difficult to study the effects of medicines on the brain. And then there’s diagnostics – by the time most people realise they have dementia, too many neurons have been destroyed for treatments to have much effect.

As Prime Minister, I made dementia a UK and global priority. I doubled funding for research; set up the National Dementia Challenge to promote innovation in pharmaceutical companies, which led to the first Dementia Discovery Fund; and I hosted the first dedicated G8 event on dementia to secure greater co-operation between leading nations.

Want to see this content?

This page contains content provided by Facebook. We ask for your permission before anything is loaded, as Facebook may use cookies and other technologies. To view this content, choose 'Accept and continue' to allow Facebook and its required purposes.

I’ve continued my mission since leaving Downing Street, becoming President of Alzheimer’s Research UK. We’ve seen extraordinary scientific advances in that time, giving real hope and cause for optimism.

It is these potential breakthroughs transforming detection and treatment – as well as my own family’s experience of the disease – that I explore in my new Bloomberg podcast, Ending Alzheimer’s.

My vision has long been for a “statin for the brain” – something we can take daily to stave off or even stop this dreadful disease from developing, just as statins have been such a wonder drug with helping to prevent heart disease.

Want to see this content?

This page contains content provided by Google reCAPTCHA. We ask for your permission before anything is loaded, as Google reCAPTCHA may use cookies and other technologies. To view this content, choose 'Accept and continue' to allow Google reCAPTCHA and its required purposes.

For the first time, a large number of new drugs, techniques and theories are being explored. We now have licensed treatments that remove amyloid from the brain, potentially slowing Alzheimer’s rate of progression by as much as 30 per cent. Blood tests that reveal the markers of the disease early on are becoming affordable and accessible. And scientists talk with genuine conviction about how AI really can transform the search for a cure.

Today, the accumulation and pace of scientific advances makes me feel more hopeful than ever. While there is still a long way to go, I am certain that someone alive today could be the first to be cured of this disease. We really are close to Ending Alzheimer’s.

The latest issue of Radio Times is out on Tuesday – subscribe here.

1-SE-48-0-Cover

Ending Alzheimer’s, a four-part Bloomberg podcast series with David Cameron, is available now.

Check out more of our Documentaries coverage or visit our TV Guide and Streaming Guide to find out what's on. For more TV recommendations and reviews, listen to The Radio Times Podcast.

View the original on Radio Times →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.